Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NextCure Inc NXTC

Healthcare Biotechnology
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing medicines that treat cancer patients that do not respond to, or have disease progression on, current therapies, through the use of differentiated mechanisms of actions including Antibody-Drug Conjugates (ADCs), antibodies, and proteins. The Company focuses on advancing therapies that leverage its... see more

Recent & Breaking News (NDAQ:NXTC)

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

GlobeNewswire 3 days ago

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta

GlobeNewswire 10 days ago

NextCure Provides Business Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

NextCure Reports Preclinical Data for LNCB74 and Additional Clinical Biomarker Data for NC410 Combo at Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire November 5, 2024

NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting

GlobeNewswire October 4, 2024

NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024

GlobeNewswire September 16, 2024

NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire August 1, 2024

NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire June 20, 2024

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024

GlobeNewswire May 30, 2024

NextCure Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire May 2, 2024

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

GlobeNewswire April 24, 2024

NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024

GlobeNewswire April 8, 2024

NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board

GlobeNewswire April 4, 2024

NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

NextCure Provides Business Update and Reports Full Year 2023 Financial Results

GlobeNewswire March 21, 2024

NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances

GlobeNewswire March 5, 2024

NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders

GlobeNewswire January 18, 2024

NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury

GlobeNewswire December 21, 2023

NextCure Provides Year-End Clinical Pipeline Updates

GlobeNewswire December 14, 2023

NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire November 20, 2023